Vaezi, A.; Salmasi, M.; Soltaninejad, F.; Salahi, M.; Javanmard, S.H.; Amra, B.
Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Adv. Respir. Med. 2023, 91, 18-25.
https://doi.org/10.3390/arm91010004
AMA Style
Vaezi A, Salmasi M, Soltaninejad F, Salahi M, Javanmard SH, Amra B.
Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Advances in Respiratory Medicine. 2023; 91(1):18-25.
https://doi.org/10.3390/arm91010004
Chicago/Turabian Style
Vaezi, Atefeh, Mehrzad Salmasi, Forogh Soltaninejad, Mehrdad Salahi, Shaghayegh Haghjooy Javanmard, and Babak Amra.
2023. "Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial" Advances in Respiratory Medicine 91, no. 1: 18-25.
https://doi.org/10.3390/arm91010004
APA Style
Vaezi, A., Salmasi, M., Soltaninejad, F., Salahi, M., Javanmard, S. H., & Amra, B.
(2023). Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Advances in Respiratory Medicine, 91(1), 18-25.
https://doi.org/10.3390/arm91010004
